Compliance & Legal
Andreessen Horowitz investment partner Jay Rughani discusses the paper he and his colleagues published recently about clinical use cases of AI, and outlined steps regulators should take for reimbursing providers using the technology.
With HTI-1 finalized, EHR vendors will have to tackle electronic case reporting while providers must look ahead and get social determinants of health into their workflows, says Don Rucker, chief strategy officer for 1upHealth.
The technology falsely tagged consumers, particularly women and people of color, as shoplifters, FTC says.
The year ahead will see policies evolving along with the tech, says Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, who discusses regulatory approaches that foster innovation while protecting safety.
The watchdog agency said that it found the existing coordination agreement does not reflect "organizational and procedural changes," including the FDA's authority to find that medical devices in use violate federal law.
The hospital "failed to handle its patients’ health information with care," said Attorney General Letitia James. It has pledged to update its policies on third-party tools, ensure deletion of PHI gathered by those tools and boost its privacy safeguards.
The DOJ announced that the FBI also has decryptor keys for Blackcat ransomware victims and will "prioritize disruptions" as it works to "dismantle the ecosystem fueling cybercrime."
AI & ML Intelligence
Leaders at ONC's annual meeting were asked whether they're confident that federal agencies and the private sector can work together to foster innovation while protecting against bias and safety risks. Here's what they had to say.
By creating new definitions and revising others, the proposed rule targets health and wellness technology companies operating outside of HIPAA and qualitatively expands the scope of what constitutes a PHR.
The American Medical Association's principles on the development and deployment of AI highlight members' concerns and consider who should be held liable, says Dr. Jesse Ehrenfeld, president of AMA, speaking from the HIMSS AI in Healthcare Forum.